🔗 Permalink

Inventor profile of:

Manuel V. Borca

City:

Westbrook, Connecticut

Country:

United States

Published Applications:

Last publication date:

2023-01-05

Top Assignees for applications by Manuel V. Borca

The entities that hold a legal rights for patent applications filed by inventor Borca Manuel V.:

The United States of America as Represented by the Secretary of Agriculture 16 Washington, DC United States
THE UNIVERSITY OF CONNECTICUT 4 Farmington, CT United States
University of Connecticut 1 Farmington, CT United States
THE UNIVERSITY OF CONNECTICUT 1 Storrs, CT United States
The University of Conneticut 1 Farmington, CT United States
Universidad del Pais Vasco/Euskal Herriko Univertsitatea (UPV-EHU) 1 , Spain

Recent patent applications by Borca Manuel V.

Manuel V. Borca from Westbrook, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-01-05

US20230000967A1

Human necessities

Development of a novel live attenuated African swine fever vaccine based in the deletion of gene A137R

#2 | 2022-06-23

US20220193217A1

Human necessities

Genomic deletion in African swine fever vaccine allowing efficient growth in stable cell lines

#3 | 2021-10-28

US20210333293A1

Physics

Continuous stable cell line for identification of infectious African swine fever virus in clinical samples

#4 | 2021-08-12

US20210244809A1

Human necessities

Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L

#5 | 2021-03-25

US20210085776A1

Human necessities

Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L

#6 | 2017-11-07

US15200407

Human necessities

Rationally developed african swine fever attenuated virus strain protects against challenge with parental virus georgia 2007 isolate

#7 | 2017-05-11

US20170128563A1

Human necessities

Live attenuated classical swine fever vaccine based in genetic manipulation of a putative fusion peptide area in the virus structural glycoprotein E2

#8 | 2016-10-25

US14309548

Human necessities

African swine fever virus georgia strain adapted to efficiently grow in the vero cell line

#9 | 2016-05-12

US20160130562A1

Chemistry; metallurgy

Attenuated African swine fever virus vaccine based in the deletion of MGF genes

#10 | 2016-03-24

US20160082099A1

Human necessities

Attenuated african swine fever virus strain induces protection against challenge with homologous virulent parental virus georgia 2007 isolate

#11 | 2015-09-10

US20150250866A1

Human necessities

Live attenuated antigenically marked classical swine fever vaccine

#12 | 2012-01-19

US20120014992A1

Chemistry; metallurgy

N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine

#13 | 2010-11-25

US20100297175A1

Human necessities

Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain brescia influences virulence in swine

#14 | 2008-11-27

US20080292653A1

Chemistry; metallurgy

Live attenuated antigenically marked classical swine fever virus

#15 | 2008-02-19

US11316755

Classical swine fever virus virulence determinant and a novel classical swine fever vaccine

#16 | 2007-12-06

US20070280955A1

Human necessities

Virulence determinant within the E2 structural glycoprotein of classical swine fever virus

InventorID:

1280210 ⎘